Literature DB >> 25305151

Performance assessment of the BD MAX Cdiff assay in comparison to Xpert C. difficile assay in a setting with very low prevalence of toxigenic Clostridium difficile PCR ribotype 027.

Donald Chiang1, Sally Ng1, My-Van La2, Roland Jureen1, Raymond T P Lin1, Jeanette W P Teo3.   

Abstract

In a clinical setting with low prevalence of 'epidemic' PCR ribotype 027, the BD MAX Cdiff assay was found to be a suitable alternative to the Xpert C. difficile assay for the detection of toxigenic Clostridium difficile in samples which are reflex PCR tested after obtaining a discrepant immunoassay result. There was no significant difference between the sensitivities and specificities of both commercial molecular assays.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Clostridium; Nosocomial infection; Real-time PCR

Mesh：

Year:  2014        PMID： 25305151     DOI： 10.1016/j.anaerobe.2014.09.021

Source DB:  PubMed          Journal:  Anaerobe        ISSN： 1075-9964            Impact factor:   3.331


  4 in total

1.  High Prevalence of Toxigenic and Nontoxigenic Clostridium difficile Strains in Malaysia.

Authors:  Thomas V Riley; Deirdre A Collins; Rina Karunakaran; Maria Abdul Kahar; Ariza Adnan; Siti Asma Hassan; Nadiah Hanim Zainul; F R Mohammed Rustam; Z Abd Wahab; Ramliza Ramli; Yeong Yeh Lee; Hamimah Hassan
Journal:  J Clin Microbiol       Date:  2018-05-25       Impact factor: 5.948

2.  Prevalence and molecular epidemiology of Clostridium difficile infection in Indonesia.

Authors:  D A Collins; M H Gasem; T H Habibie; I G Arinton; P Hendriyanto; A P Hartana; T V Riley
Journal:  New Microbes New Infect       Date:  2017-05-04

Review 3.  Current knowledge on the laboratory diagnosis of Clostridium difficile infection.

Authors:  Adrián Martínez-Meléndez; Adrián Camacho-Ortiz; Rayo Morfin-Otero; Héctor Jesús Maldonado-Garza; Licet Villarreal-Treviño; Elvira Garza-González
Journal:  World J Gastroenterol       Date:  2017-03-07       Impact factor: 5.742

4.  Clinical evaluation of a non-purified direct molecular assay for the detection of Clostridioides difficile toxin genes in stool specimens.

Authors:  Toshinori Hara; Hiromichi Suzuki; Tadatomo Oyanagi; Norito Koyanagi; Akihito Ushiki; Naoki Kawabata; Miki Goto; Yukio Hida; Yuji Yaguchi; Kiyoko Tamai; Shigeyuki Notake; Yosuke Kawashima; Akio Sugiyama; Keiichi Uemura; Seiya Kashiyama; Toru Nanmoku; Satoshi Suzuki; Hiroshi Yamazaki; Hideki Kimura; Hiroyuki Kunishima; Hiroki Ohge
Journal:  PLoS One       Date:  2020-06-03       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.